Page last updated: 2024-08-21

adamantane and Graft-Versus-Host Disease

adamantane has been researched along with Graft-Versus-Host Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bourrié, B; Bribes, E; Casellas, P; De Nys, N; Esclangon, M; Galiègue, S; Garcia, L; Lair, P; Paul, R; Thomas, C; Vernières, JC1

Other Studies

1 other study(ies) available for adamantane and Graft-Versus-Host Disease

ArticleYear
SSR125329A, a high affinity sigma receptor ligand with potent anti-inflammatory properties.
    European journal of pharmacology, 2002, Dec-05, Volume: 456, Issue:1-3

    Topics: Adamantane; Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Binding, Competitive; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Enterotoxins; Female; Graft vs Host Disease; Interleukin-10; Ligands; Lipopolysaccharides; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred Strains; Protein Subunits; Receptors, sigma; Spleen; Steroid Isomerases; Syndrome; Tumor Necrosis Factor-alpha

2002